BF3-Et2O mediated biogenetic type synthesis of chromanochalcones from prenylated chalcones via a regioselective cyclization reaction

Tetrahedron Letters

Volumn 48, Issue 43, 2007, Pages 7628-7632

  Narender, T ^a   Reddy, K Papi ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

BF3 Et2O; Biogenetic type synthesis; Chromanochalcones; Regioselective cyclization

Indexed keywords

ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BORONTRIFLUORIDE ETHERATE; CHALCONE DERIVATIVE; CHROMANOCHALCONE; CLUSIFOLIOL; CROTAMADINE; CROTARAMIN; CROTARAMOSMIN; CROTINE; DIHYDROCHROMANOCHALCONE; DORSMANIN A; FLAVANONE; FLUORIDE; NATURAL PRODUCT; TROGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; BIOGENESIS; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; PRENYLATION;

EID: 34548844156     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2007.08.124     Document Type: Article

References (25)

1. Kashman Y., Gustafson K.R., Fuller R.W., Cardellina J.H., McMahon II J.B., Currens M.J., Buckheit R.W., Hughes Jr. S.H., Cragg G.M., and Boyd M.R. J. Med. Chem. 35 (1992) 2735-2743
2. Currens M.J., Mariner J.M., McMahon J.B., and Boyd M.R. J. Pharmacol. Exp. Ther. 279 (1996) 652-661
3. Bergmann R., and Gericke R. J. Med. Chem. 33 (1990) 492-504
4. Gericke R., Harting J., Lues I., and Schittenhelm C. J. Med. Chem. 34 (1991) 3074-3085
5. Srivastava R.P., and Proksch P. Entomol. Gen. 15 (1991) 265-274
6. Burton G.W., and Ingold K.U. Ann. N.Y. Acad. Sci. 570 (1989) 7-22
7. Harada T., Hayashiya T., Wada I., Iwaake N., and Oku A. J. Am. Chem. Soc. 109 (1987) 527-532
8. Inoue S., Ikeda H., Sato S., Horie K., Ota T., Miyamoto O., and Sato K. J. Org. Chem. 52 (1987) 5495-5497
9. Seeram N.P., Jacobs H., McLean S., and Reynolds W.F. Phytochemistry 49 (1998) 1389-1391
10. Tanaka T., Asai F., and Iinuma M. Phytochemistry 49 (1998) 229-232
11. Matsumoto K., Miyake S., Yano M., Ueki Y., and Tominaga Y. Lancet 350 (1997) 1748
12. Nicolaou K.C., Pfefferkorn J.A., Roecker A.J., Cao G.-Q., Barluenga S., and Mitchell H.J. J. Am. Chem. Soc. 122 (2000) 9939-9953
13. Pushpa B., and Rameshwar D. Indian J. Chem. 41B (2002) 184-186
14. Charles D.H., and William A.H. J. Org. Chem. 5 (1940) 212-222
15. William G.D., Jeffrey M.C., and Victor B. Tetrahedron Lett. 31 (1990) 3241-3244
16. Bigi F., Carloni S., Maggi R., Muchetti C., Rastelli M., and Sartori G. Synthesis (1998) 301-304
17. Wang Y., Wu J., and Xia P. Synth. Commun. 36 (2006) 2685-2698
18. Narender T., Shweta, Tanvir K., Rao M.S., Srivastava K., and Puri S.K. Bioorg. Med. Chem. Lett. 15 (2005) 2453-2455
19. Kumar J.K., Narender T., Rao M.S., Rao P.S., Toth G., Balazs B., and Duddeck H. J. Braz. Chem. Soc. 10 (1999) 278-280
20. Narender T., Shweta, and Gupta S. Bioorg. Med. Chem. Lett. 14 (2004) 3913-3916
21. Narender T., Tanvir K., Shweta, Nishi, Goyal N., and Gupta S. Bioorg. Med. Chem. 13 (2005) 6543-6550
22. Ngadjui B.T., Abegaz B.M., Dongo E., Tamboue H., and Fogue K. Phytochemistry 48 (1998) 349-354
23. Bhakuni D.S., and Chaturvedi R. J. Nat. Prod. 47 (1984) 585-591
24. Narender T., and Reddy K.P. Tetrahedron Lett. 48 (2007) 3177-3180
25. 4 and evaporated under reduced pressure. The crude mixture was purified by silica gel column chromatography to afford chromanochalcone 1b (485 mg, 97%).